Form D · Biotechnology

FlightPath Biosciences, Inc.

Birmingham, MI · CIK 0001809914

Offering snapshot reported Oct 24, 2024 · SEC filing

Reported sold
$8.06M
Offering amount: $9M
Investors reported
17
Form D · investor count
Minimum accepted
$0
Reported outside-investor minimum
First sale
Feb 13, 2023
As reported in this filing

Fundraising history

Reported sold
Reported amount sold by Form D filing date$0$4.03M$8.06MFeb 15, 2023: $1,100,000.00Feb 15, 2023Oct 24, 2024: $8,064,826.00Oct 24, 2024

Dates are filing dates, not cash receipt dates. Decreases are reported revisions, not evidence of withdrawals. Separate offering histories are not added together.

What changed?

Latest filing versus its linked predecessor, where available.

  • Reported sold$1,100,000 → $8,064,826
  • Reported investors6 → 17

Filing history

Scroll to see all columns →

FiledFiling typeReported soldChange vs linked filingInvestorsSource
Oct 24, 2024Amendment$8,064,826$6,964,826vs Feb 15, 202317SEC filing
Feb 15, 2023Initial$1,100,000No comparison6SEC filing
Dec 16, 2021Amendment$1,522,000$1,172,000vs Apr 17, 20201SEC filing
Apr 17, 2020Initial$350,000No comparison1SEC filing

Offering details

Securities
Equity
Exemptions
06b
Duration over one year
Yes
Business combination
No
Sales commissions
$0
Finders' fees
$0
Form D file number
021-473544

Source: Form D, filed Oct 24, 2024. Minimum accepted may differ from a standard advertised minimum.

Fund connections

No confirmed ADV fund connection is available for this issuer.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
NameReported role
Mark De Souza Director
Cristina Larkin Director
Jayakumar Rajadas Director
Curtis Scribner Director
Matthew Tindall Director, Executive

Issuer details

Industry: Biotechnology (See others in industry)

Address:
15 Fairfax Street
Birmingham, MI, 48009